Tag: Amgen
Amgen’s breakthrough obesity drug AMG 133 sparks investor frenzy
by Editor | Feb 9, 2024 | LATEST NEWS, Mergers, Investments & Funding, WORLD NEWS | 0
During Amgen’s recent fourth-quarter earnings call conference on Tuesday, February 6, Wall Street analysts were enthusiastic about the prospects of AMG 133, an experimental GLP-1 drug intended for the treatment of obesity.
Read MorePharmaceutical giants capitalize on soaring obesity rates with revolutionary weight-loss drugs
by Editor | Nov 20, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA – Obesity rates in the United States have witnessed a relentless ascent for well over a...
Read MoreAmgen successfully completes US$27.8 billion acquisition of Horizon Therapeutics after FTC challenge
by Editor | Oct 9, 2023 | LATEST NEWS, Mergers, Investments & Funding, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — Amgen has successfully concluded its ambitious US$27.8 billion acquisition of Horizon...
Read MoreFTC halts Amgen’s Horizon Therapeutics acquisition amid antitrust concerns
by Editor | Aug 28, 2023 | Government, Regulatory & Policy News, LATEST NEWS, Mergers, Investments & Funding, WORLD NEWS | 0
USA — In a pivotal twist, the US Federal Trade Commission (FTC) has momentarily paused its...
Read MorePharma veteran Paul Burton returns to Amgen as Senior Vice President and Chief Medical Officer
by Editor | Jun 15, 2023 | LATEST NEWS, People News, WORLD NEWS | 0
USA — After nearly two decades, esteemed pharmaceutical veteran Paul Burton, M.D., Ph.D., is...
Read MoreFederal Trade Commission takes strong stance against Amgen’s acquisition of Horizon Therapeutics
by Editor | May 17, 2023 | Government, Regulatory & Policy News, LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — The Federal Trade Commission (FTC) has made a bold move to block Amgen’s US$27.8...
Read MoreAmgen to reduce workforce by 450 in second round of layoffs for 2023
by Editor | Mar 17, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — Amgen Inc has announced its plans to cut 450 jobs, which constitutes less than 2% of its...
Read MoreU.S. FDA approves Amgen-AstraZeneca’s Tezspire for asthma treatment
by Editor | Feb 6, 2023 | Government, Regulatory & Policy News, LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — The U.S. Food and Drug Administration (FDA) has granted approval to Amgen and AstraZeneca’s...
Read MoreAmgen launches biosimilar version of AbbVie’s Humira, ending its two-decade reign
by Editor | Feb 1, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — Amgen is set to launch a biosimilar to the widely prescribed Humira, giving physicians and...
Read MoreAmgen commits US$8m to clinical trial diversity program
by Editor | Jan 27, 2023 | LATEST NEWS, Mergers, Investments & Funding, Science, Technology & Research, WORLD NEWS | 0
USA — Amgen has committed to contribute US$8 million to the Robert A. Winn Diversity in Clinical...
Read MoreAmgen outlasts competitors to clinch Horizon Therapeutics in year’s biggest biotech deal
by Editor | Dec 15, 2022 | LATEST NEWS, Mergers, Investments & Funding, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — Amgen has agreed to acquire Horizon Therapeutics of Ireland, outlasting rival suitors Sanofi...
Read MoreAmgen issues maiden US$750 million green bond
by Editor | Feb 23, 2022 | Hospitals, LATEST NEWS, WORLD NEWS | 0
USA –Amgen has announced the issuance of its first US$750 million green bond, with a semi-annual...
Read More